Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzab MV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Neucure Lifesciences Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimzab MV 1mg/500mg/0.3mg Tablet

Glimzab MV 1mg/500mg/0.3mg tablets are antidiabetic medications combining multiple agents for adult type 2 diabetes management. This formulation assists in regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic effect. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Glimzab MV 1mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Glimzab MV 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimzab MV 1mg/500mg/0.3mg tablets on an empty stomach.

Common Side effects of Glimzab MV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimzab MV 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimzab MV 1mg/500mg/0.3mg Tablets should be administered on an empty stomach.

How Glimzab MV 1mg/500mg/0.3mg Tablet works:

Each Glimzab MV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimzab MV 1mg/500mg/0.3mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimzab MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimzab MV 1mg/500mg/0.3mg tablets while breastfeeding is likely unsafe. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glimzab MV 1mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimzab MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Low initial doses are usually prescribed for individuals with mild to moderate hepatic dysfunction; however, its administration is contraindicated in those with severe liver disease.

What if you forget to take Glimzab MV 1mg/500mg/0.3mg Tablet :

Should you forget to take your Glimzab MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimzab MV 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimzab MV 1mg/500mg/0.3mg Tablet

Glimzab MV 1mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This treatment improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 DM.
Glimzab MV 1mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory infections.
Glimzab MV 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimzab MV 1mg/500mg/0.3mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimzab MV 1mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly sealed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimzab MV 1mg/500mg/0.3m...
108
MRP 125
13% off